FT News Briefing

Covid-19 vaccine makers seek protections, US homebuilder stocks rise, Ant IPO

European vaccine makers want EU exemptions that would protect them if there are problems with new Covid-19 vaccines, and low interest rates have helped US homebuilder stocks surge to record highs. Plus, the FT’s James Fontanella-Khan explains why Ant Group chose to list its potentially record setting IPO outside the US.  Covid-19 vaccine makers lobby EU for legal protection<a href="https://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d?" rel="noopener noreferrer" target="_blank">https://www.ft.com/content/12f7da5b-92c8-4050-bcea-e726b75eef4d?</a> Low rates help propel US homebuilder stocks to record highs<a href="https://www.ft.com/content/9b54ab06-2d57-44a1-85c2-47c114589c22" rel="noopener noreferrer" target="_blank">https://www.ft.com/content/9b54ab06-2d57-44a1-85c2-47c114589c22</a> Ant Group reveals $2.6bn profit as it files for blockbuster IPO<a href="https://www.ft.com/content/b5f6fed2-2dcf-48dc-9097-a49bff5532dc" rel="noopener noreferrer" target="_blank">https://www.ft.com/content/b5f6fed2-2dcf-48dc-9097-a49bff5532dc</a> Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.

A rundown of the most important global business stories you need to know for the coming day, from the newsroom of the Financial Times. Available every weekday morning. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer" style="color:grey;" target="_blank">acast.com/privacy</a> for more information.